Get the Stockscreener App
119.85
0.88%
1.04
Transmedics Group Inc stock is traded at $119.85, with a volume of 1.03M.
It is up +0.88% in the last 24 hours and up +13.49% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$118.81
Open:
$118.37
24h Volume:
1.03M
Relative Volume:
1.07
Market Cap:
$4.09B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
127.50
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
-6.04%
1M Performance:
+13.49%
6M Performance:
+66.57%
1Y Performance:
-30.86%
1-Day Range:
$117.17
$121.79
1-Week Range:
$117.17
$129.01
52-Week Range:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
119.85 | 4.28B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance
TransMedics Group, Inc. $TMDX Shares Sold by Vanguard Group Inc. - MarketBeat
Identifying reversal signals in TransMedics Group Inc.2025 Technical Patterns & Smart Investment Allocation Tips - Newser
Public Sector Pension Investment Board Raises Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
Liontrust Investment Partners LLP Sells 42,044 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Will TransMedics Group Inc. outperform the marketJuly 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TransMedics Group Inc. stock trend forecast2025 Performance Recap & Growth-Oriented Investment Plans - Newser
Multi asset correlation models including TransMedics Group Inc.Quarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
2025-08-19 | Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect | NDAQ:TMDX | Press Release - Stockhouse
Does TransMedics Group Inc. qualify in momentum factor screeningEntry Point & Technical Pattern Alert System - Newser
PNC Financial Services Group Inc. Increases Stake in TransMedics Group, Inc. $TMDX - Defense World
Trillium Asset Management LLC Grows Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Advanced analytics toolkit walkthrough for TransMedics Group Inc.Quarterly Market Review & Precise Trade Entry Recommendations - Newser
Published on: 2025-08-17 15:54:01 - Newser
When is the best time to buy TransMedics Group Inc. stockEarnings Overview Summary & AI Powered Buy/Sell Recommendations - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Mitsubishi UFJ Asset Management Co. Ltd. Acquires 24,200 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Montanaro Asset Management Ltd Grows Stake in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Is TransMedics Group Inc. reversing from oversold territory2025 Investor Takeaways & Long-Term Growth Portfolio Plans - Newser
Should you hold or exit TransMedics Group Inc. nowWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Can TransCode Therapeutics Inc. expand its profit marginsPortfolio Performance Report & Verified Short-Term Trading Plans - thegnnews.com
Is TransMedics Group Inc. forming a breakout patternJuly 2025 Setups & Weekly Setup with ROI Potential - thegnnews.com
Is TransMedics Group Inc. a good ESG investmentQuarterly Market Summary & Accurate Intraday Trading Signals - mustnews.co.kr
TransMedics Sees Its Earnings Soar - AOL.com
Is TransMedics Group Inc. currently under institutional pressure2025 Dividend Review & Low Drawdown Momentum Trade Ideas - sundaytimes.kr
Is Scienture Holdings Inc. forming a reversal pattern2025 Performance Recap & Technical Pattern Alert System - Newser
TransMedics Group (NASDAQ:TMDX) Shares Gap UpTime to Buy? - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Call Transcript - msn.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
3 Insider Transactions to Watch in IonQ, Hims and Hers, Eli Lilly, and TransMedics - AInvest
Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics - TradingView
Is TransMedics Group Inc. affected by consumer sentimentPortfolio Value Summary & Accurate Entry/Exit Alerts - thegnnews.com
Headlands Technologies LLC Has $562,000 Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
3 Unusual Insider Transactions you Should Know About - Zacks Investment Research
How moving averages guide TransMedics Group Inc. tradingMarket Performance Recap & Fast Exit and Entry Strategy Plans - Newser
What Technical Tools Say About TransMedics Group Inc. RecoveryOil Prices & Short-Term Trading Alerts - 선데이타임즈
Is TransMedics Group Inc. a candidate for recovery playRate Hike & Daily Stock Trend Reports - Newser
Can TransMedics Group Inc. hit a new high this monthYield Curve Outlook and Long-Term Implication Summary - Newser
How TransMedics Group Inc. stock performs during market volatility [Weekly Loss Report]Free AI Powered Market Trend Analysis - Newser
How to monitor TransMedics Group Inc. with trend dashboardsFree Daily Chart Pattern Stock Forecast - Newser
Live market analysis of TransMedics Group Inc.Pattern Breakout Tracker with Screener Tools - Newser
Transmedics Group Inc (TMDX) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hassanein Waleed H | President & CEO |
Aug 07 '25 |
Buy |
116.25 |
8,475 |
985,209 |
486,234 |
| Basile Edward M | Director |
Aug 04 '25 |
Option Exercise |
0.70 |
4,143 |
2,900 |
7,009 |
| Basile Edward M | Director |
Aug 04 '25 |
Sale |
125.51 |
4,143 |
519,988 |
2,866 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):